{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:48:16Z","timestamp":1792716496823,"version":"4.5.0"},"reference-count":58,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2015,7,17]],"date-time":"2015-07-17T00:00:00Z","timestamp":1437091200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0133278","type":"journal-article","created":{"date-parts":[[2015,7,17]],"date-time":"2015-07-17T14:14:11Z","timestamp":1437142451000},"page":"e0133278","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":10,"title":["Relationship between Fibroblast Growth Factor 23 and Biochemical and Bone Histomorphometric Alterations in a Chronic Kidney Disease Rat Model Undergoing Parathyroidectomy"],"prefix":"10.1371","volume":"10","author":[{"given":"Hung-Wei","family":"Liao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peir-Haur","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Yen","family":"Hsiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung-Hsiang","family":"Liou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsin-Shih","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsang-Hai","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I-Ming","family":"Jou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuen-Jer","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,7,17]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1681\/ASN.2006070771","article-title":"Metabolic bone disease in chronic kidney disease","volume":"18","author":"KJ Martin","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1471-2369-11-17","article-title":"Fracture Risk Assessment in Chronic Kidney Disease, Prospective Testing Under Real World Environments (FRACTURE): a prospective study","volume":"11","author":"SL West","year":"2010","journal-title":"BMC Nephrol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1093\/ndt\/gfq491","article-title":"The link between bone and coronary calcifications in CKD-5 patients on haemodialysis","volume":"26","author":"G Asci","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S0272-6386(04)00958-8","article-title":"Increased risk of mortality associated with hip fracture in the dialysis population","volume":"44","author":"A Mittalhenkle","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1038\/ki.2009.405","article-title":"Clinical relevance of FGF-23 in chronic kidney disease","volume":"114","author":"S Seiler","year":"2009","journal-title":"Kidney Int Suppl"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/j.bone.2007.01.017","article-title":"Mineralized tissue cells are a principal source of FGF23","volume":"40","author":"Y Yoshiko","year":"2007","journal-title":"Bone"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/jbmr.320","article-title":"The amazing osteocyte","volume":"26","author":"LF Bonewald","year":"2011","journal-title":"J Bone Miner Res"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.bbrc.2003.12.102","article-title":"FGF-23 transgenic mice demonstrate hypophosphatemic rickets with reduced expression of sodium phosphate cotransporter type IIa","volume":"314","author":"T Shimada","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/JOE-07-0095","article-title":"The emerging role of the fibroblast growth factor-23-klotho axis in renal regulation of phosphate homeostasis","volume":"194","author":"MS Razzaque","year":"2007","journal-title":"J Endocrinol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1038\/sj.ki.5002000","article-title":"Acute effect of oral phosphate loading on serum fibroblast growth factor 23 levels in healthy men","volume":"70","author":"Y Nishida","year":"2006","journal-title":"Kidney Int"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"383","DOI":"10.2215\/CJN.04730510","article-title":"Effects of dietary phosphate and calcium intake on fibroblast growth factor-23","volume":"6","author":"MG Vervloet","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1038\/ki.2009.83","article-title":"Phosphate feeding induces arterial medial calcification in uremic mice: role of serum phosphorus, fibroblast growth factor-23, and osteopontin","volume":"75","author":"MM El-Abbadi","year":"2009","journal-title":"Kidney Int"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.2215\/CJN.08241109","article-title":"Fibroblast Growth factor-23 in Early Chronic Kidney Disease: Additional Support in Favor of a Phosphate-Centric Paradigm for the Pathogenesis of Secondary Hyperparathyroidism","volume":"5","author":"P Evenepoel","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1681\/ASN.2005010052","article-title":"Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease","volume":"16","author":"O Gutierrez","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"4835","DOI":"10.1210\/en.2009-0472","article-title":"Bone formation regulates circulating concentrations of fibroblast growth factor 23","volume":"150","author":"R Samadfam","year":"2009","journal-title":"Endocrinology"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1056\/NEJM199507203330307","article-title":"Renal osteodystrophy","volume":"333","author":"KA Hruska","year":"1995","journal-title":"N Engl J Med"},{"issue":"Suppl 10","key":"ref17","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/ndt\/17.suppl_10.2","article-title":"Renal osteodystrophy and secondary hyperparathyroidism","volume":"17","author":"M Fukagawa","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/jbmr.516","article-title":"Longitudinal evaluation of FGF23 changes and mineral metabolism abnormalities in a mouse model of chronic kidney disease","volume":"27","author":"JR Stubbs","year":"2012","journal-title":"J Bone Miner Res"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1007\/s00198-009-1142-4","article-title":"Fibroblast growth factor-23 is associated with C-reaction protein, serum phosphate and bone mineral density in chronic kidney disease","volume":"21","author":"P Manghat","year":"2010","journal-title":"Osteoporos Int"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1681\/ASN.2011101006","article-title":"Calcium deficiency reduces circulating levels of FGF23","volume":"23","author":"ME Rodriguez-Ortiz","year":"2012","journal-title":"J Am Soc Nephro"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1093\/ndt\/gfn686","article-title":"Phosphorus overload and PTH induce aortic expression of Runx2 in experimental uremia","volume":"24","author":"FG Graciolli","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"e79721","DOI":"10.1371\/journal.pone.0079721","article-title":"Effects of dietary phosphate on adynamic bone disease in rats with chronic kidney disease\u2014role of sclerostin?","volume":"8","author":"JC Ferreira","year":"2013","journal-title":"PLos One"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1038\/ki.1991.315","article-title":"Calcemic response to parathyroid hormone in renal failure: role of calcitriol and the effect of parathyroidectomy","volume":"40","author":"M Rodriguez","year":"1991","journal-title":"Kidney Int"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/jbmr.5650020617","article-title":"Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee","volume":"2","author":"AM Parfitt","year":"1987","journal-title":"J Bone Miner Res"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S8756-3282(99)00257-4","article-title":"Normative data for iliac bone histomorphometry in growing children","volume":"26","author":"FH Glurieux","year":"2000","journal-title":"Bone"},{"issue":"Suppl 3","key":"ref26","doi-asserted-by":"crossref","first-page":"S151","DOI":"10.2215\/CJN.04301206","article-title":"Histomorphometric measurements of bone turnover, mineralization, and volume","volume":"3","author":"SM Ott","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","article-title":"Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"69","author":"S Moe","year":"2006","journal-title":"Kidney Int"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/1479-5876-11-201","article-title":"The clinical utility of bone marker measurements in osteoporosis","volume":"11","author":"G Wheater","year":"2013","journal-title":"J Transl Med"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.bone.2011.06.025","article-title":"Parathyroid hormone receptor signaling in osteocytes increases the expression of fibroblast growth factor-23 in vitro and in vivo","volume":"49","author":"Y Rhee","year":"2011","journal-title":"Bone"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/j.bone.2007.03.017","article-title":"Molecular and cellular mechanisms of the anabolic effect of intermittent PTH","volume":"40","author":"RL Jilka","year":"2007","journal-title":"Bone"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"F882","DOI":"10.1152\/ajprenal.00360.2010","article-title":"PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: a bone parathyroid feedback loop","volume":"299","author":"V Lavi-Moshayoff","year":"2010","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/ki.2011.107","article-title":"Direct and indirect effects of parathyroid hormone on circulating levels of fibroblast growth factor 23 in vivo","volume":"80","author":"I L\u00f3pez","year":"2011","journal-title":"Kidney Int"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1681\/ASN.2006070783","article-title":"Parathyroid hormone regulates fibroblast growth factor-23 in a mouse model of primary hyperparathyroidism","volume":"8","author":"T Kawata","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0272-6386(04)00817-0","article-title":"Total parathyroidectomy reduces elevated circulating fibroblast growth factor 23 in advanced secondary hyperparathyroidism","volume":"44","author":"T Sato","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"F1577","DOI":"10.1152\/ajprenal.00463.2006","article-title":"Fibroblast growth factor 23 impairs phosphorus and vitamin D metabolism in vivo and suppresses 25-hydroxyvitamin D 1-alpha-hydroxylase expression in vitro","volume":"293","author":"F Perwad","year":"2007","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/ndt\/gfn260","article-title":"The bone-renal axis in early chronic kidney disease: an emerging paradigm","volume":"23","author":"J Danziger","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"4469","DOI":"10.1210\/en.2013-1627","article-title":"Calcium regulates FGF-23 expression in bone","volume":"154","author":"V David","year":"2013","journal-title":"Endocrinology"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/ki.1993.64","article-title":"The spectrum of bone disease in end-stage renal failure\u2014an evolving disorder","volume":"43","author":"DJ Sherrard","year":"1993","journal-title":"Kidney Int"},{"key":"ref39","first-page":"457","article-title":"Watching bone cells at works: what can we see from bone biopsies","volume":"21","author":"F Rauch","year":"2006","journal-title":"Watching bone cells at works: what can we see from bone biopsies"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"33086","DOI":"10.1074\/jbc.M705194200","article-title":"Determination of duel effects of parathyroid hormone on skeletal gene expression in vivo by microarray and network analysis","volume":"282","author":"X Li","year":"2007","journal-title":"J Biol Chem"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s11154-010-9153-1","article-title":"Cellular mechanism of bone remodeling","volume":"11","author":"EF Eriksen","year":"2010","journal-title":"Rev Endocr Metab Disord"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1681\/ASN.2006070771","article-title":"Metabolic bone disease in chronic kidney disease","volume":"18","author":"KJ Martin","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1002\/jbmr.126","article-title":"Increased osteocyte death and mineralization inside bone after parathyroidectomy in patients with secondary hyperparathyroidism","volume":"25","author":"A Yajima","year":"2010","journal-title":"J Bone Miner Res"},{"key":"ref44","first-page":"411","article-title":"Evolution of osteocalcin, alkaline phosphatase and parathyroid hormone after parathyroidectomy in patients receiving chronic maintenance hemodialysis","volume":"19","author":"AM Peretz","year":"1992","journal-title":"J Rheumatol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1093\/ndt\/15.6.877","article-title":"Changes in bone turnover after parathyroidectomy in dialysis patients: role of calcitriol administration","volume":"15","author":"S Mazzaferro","year":"2000","journal-title":"Nephrol Dial Transplant"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/j.1365-2265.2011.04265.x","article-title":"Bone turnover markers predict changes in bone mineral density after parathyroidectomy in patients with renal hyperparathyroidism","volume":"76","author":"KC Lu","year":"2012","journal-title":"Clin Endocrinol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"3845","DOI":"10.1210\/jcem.83.11.5249","article-title":"Bone mineral recovery after parathyroidectomy in patients with primary and renal hyperparathyroidism","volume":"83","author":"M Abdelhadi","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1002\/jbmr.1985","article-title":"Association of Serum Fibroblast Growth Factor 23 (FGF23) and Incident Fractures in Older Men: The Osteoporotic Fractures in Men (MROS) Study","volume":"28","author":"NE Lane","year":"2013","journal-title":"J Bone Miner Res"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s00223-011-9501-5","article-title":"Fibroblast growth factor (FGF-23) and alpha-kltho stimulate osteoblastic MC3T3.E1 cell proliferation and inhibit mineralization","volume":"89","author":"V Shalhoub","year":"2011","journal-title":"Calcif Tissue Int"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"e32177","DOI":"10.1371\/journal.pone.0032177","article-title":"Altered bone development and an increase in FGF-23 expression in Enpp(-\/-) mice","volume":"7","author":"NC Mackenzie","year":"2012","journal-title":"PLos one"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1007\/s00198-009-1142-4","article-title":"Fibroblast growth factor-23 is associated with C-reactive protein, serum phosphate and bone mineral density in chronic kidney disease","volume":"21","author":"P Manghat","year":"2010","journal-title":"Osteoporos Int"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1007\/s00198-011-1838-0","article-title":"FGF23 is independently associated with vascular calcification but not bone mineral density in patient at various CKD stages","volume":"23","author":"L Desjardins","year":"2012","journal-title":"Osteoporos Int"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"E1901","DOI":"10.1210\/jc.2013-2418","article-title":"Diabetes modifies effect of high-phosphate diet on fibroblast growth factor-23 in chronic kidney disease","volume":"98","author":"K Muras","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"E2036","DOI":"10.1210\/jc.2012-2024","article-title":"Impair response of FGF-23 to oral phosphate in patients with type 2 diabetes: a possible mechanism of atherosclerosis","volume":"97","author":"K Yoda","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.2337\/dc13-2235","article-title":"FGF23 in type 2 diabetic patients: relationship between bone metabolism and vascular disease","volume":"37","author":"R Reyes-Garcia","year":"2014","journal-title":"Diabetes Care"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.bone.2009.08.008","article-title":"Patterns of FGF-23, DMP1 and MEPE expression in patients with chronic kidney disease","volume":"45","author":"RC Pereira","year":"2009","journal-title":"Bone"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1210\/jc.2008-0326","article-title":"Relationship between plasma fibroblast growth factor-23 concentration and bone mineralization in children with renal failure on peritoneal dialysis","volume":"94","author":"K Wesseling-Perry","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2215\/CJN.05940611","article-title":"Early skeletal and biochemical alterations in pediatric chronic kidney disease","volume":"7","author":"K Wesseling-Perry","year":"2012","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0133278","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T06:34:02Z","timestamp":1566974042000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0133278"}},"subtitle":[],"editor":[{"given":"Ching-Po","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,7,17]]},"references-count":58,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2015,7,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0133278","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,17]]}}}